SCHEMBL25834188

SCHEMBL25834188

CCOCCS(=O)(=O)NS(C)(=O)=O

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.32
LOX P28300 1/20 0.32
TSHR P16473 1/20 0.31
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25834192 0.96 ALDH1A1 (0.33) ALDH1A1LOXTSHRGAA
SCHEMBL3437740 0.89 ALDH1A1 (0.36) ALDH1A1LOXTSHRGAA
SCHEMBL25834190 0.79 CA2 (0.39)
SCHEMBL25834195 0.79 TSHR (0.40) ALDH1A1TSHR
SCHEMBL14459501 0.77 ALDH1A1 (0.35) ALDH1A1LOXTSHRGAA
SCHEMBL14616647 0.77 USP2 (0.35) TSHR
SCHEMBL6698147 0.74 CA1 (0.32)
SCHEMBL3437725 0.74
SCHEMBL26495001 0.74 ALDH1A1 (0.41) ALDH1A1TSHR
SCHEMBL6506909 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230218523-A1 Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230218523-A1 Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents HACD3, C9, HACD2 ALDH1A1 3671/4885LOX 4698/4885TSHR 3859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.